AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
Top Cited Papers
- 1 February 2008
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 13 (2) , 167-180
- https://doi.org/10.1016/j.ccr.2008.01.007
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01-CA62242, P50-CA100707, RO1-AG020686, RO1-CA129009, RO1-CA83724)
- Multiple Myeloma Research Foundation
This publication has 67 references indexed in Scilit:
- Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic miceProceedings of the National Academy of Sciences, 2007
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeBlood, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaBlood, 2005
- ANTIGEN-SPECIFIC MEMORY B CELL DEVELOPMENTAnnual Review of Immunology, 2005
- Reverse engineering of regulatory networks in human B cellsNature Genetics, 2005
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003
- Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersBritish Journal of Haematology, 1999
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- IgG Myeloma Cryoglobulin with Antistreptolysin ActivityNature, 1968